The Copley Consulting Group Selected by Femasys to Deploy Infor CloudSuite™ Industrial Solution

Share Article

Femasys leverages The Copley Consulting Group's ERP implementation expertise for a seamless CloudSuite installation

The Copley Consulting Group announces that Femasys Inc., a developer of innovative medical solutions for the women's healthcare market, has selected The Copley Consulting Group to facilitate and deploy Infor’s CloudSuite Industrial (SyteLine) solution. The CloudSuite Industrial solution will enable Femasys to scale operations rapidly and meet the expanding customer and market demands with an exceptionally high level of quality. The Copley Consulting Group is providing installation, training, education, and implementation consulting to facilitate Femasys’ deployment of the fully-integrated enterprise solution.

"We are very excited about this partnership with Femasys,” said William Cary, VP of Sales at The Copley Consulting Group. “Through this collaboration, we’ll successfully implement a solution that will allow for a dynamic flow of information between Femasys, its suppliers, and the health care providers to provide timely delivery of high quality products, which are in full compliance with all FDA regulations, to satisfy the patient’s need.”

About Femasys:

Femasys is a privately held corporation committed to transforming women's healthcare worldwide by expanding options for women with innovative medical solutions and next generation advancements providing significant clinical impact. Additional information about Femasys and the Company’s products can be found at http://www.femasys.com.

Femasys has developed a groundbreaking non-surgical female sterilization solution (FemBloc® Permanent Contraceptive System*) that allows physicians to deliver exclusively in their office a Biopolymer through a catheter-based Delivery System to permanently block the fallopian tubes in a procedure that substantially reduces patient risks and costs by eliminating the use of anesthesia and permanent implants. The company has also expanded options for women with its two commercially available products for diagnosis of infertility (FemVue® Saline-Air device) and cervical cancer (FemCerv® Endocervical Sampler) that present significant advantages for the patient, physician, and healthcare system.

*FemBloc Permanent Contraceptive System is not commercially available for sale.
Femasys, FemBloc, FemVue and FemCerv are registered trademarks of Femasys Inc.
All rights reserved.

About The Copley Consulting Group:

For over 25 years, The Copley Consulting Group has delivered Infor SyteLine implementation success to more than 400 enterprises. From Fortune 1000 companies to start-up operations, Copley has provided education, training and technical services melded with a focus on Best Practices. As one of Infor’s premier Gold Level Channel Partners, Copley’s team of dedicated professionals is committed to increasing the productivity and profitability of our customers.
http://www.copleycg.com

Femays Corporate Development:    
Steven Damon
770.500.3910, ext. 120
sdamon(at)femasys(dot)com

Femasys Media Inquiries:
Jerry Fink
770.500.3910, ext. 132
jfink(at)femasys(dot)com

The Copley Consulting Group Media Inquiries:
Jason King
855-884-5305 ext. 297
jking(at)copleycg(dot)com

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Jason King
Visit website